BSE - Delayed Quote INR
Gennex Laboratories Limited (GENNEX.BO)
13.24
-0.58
(-4.20%)
At close: April 25 at 3:45:43 PM GMT+5:30
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Arihant Baid | Chairman & MD | 3.03M | -- | 1986 |
| Mr. Dinesh Kumar Kejriwal | Company Secretary & Compliance Officer | -- | -- | 1964 |
| Mr. Akkali Santosh Kumar | Chief Financial Officer | -- | -- | -- |
| Mr. K. V. L. N. Bhaswanth | Chief Operating Officer | -- | -- | -- |
Gennex Laboratories Limited
Plot No. 144, Akash Ganga Complex
3rd Floor Srinagar Colony
Hyderabad, 500 073
India
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 129
Description
Gennex Laboratories Limited engages in manufacturing and selling of bulk drugs, intermediates, and biotech products. The company offers Guaifenesin, Methocarbamol, Fexifenadine Hcl, Phenazopyridine Hcl, Fluconazole, Melitracen Hcl, Mephenesin, Chlorphenesin, Sertraline Hcl, and Allopurinol. It operates in India, Colombia, Egypt, Germany, Iran, Peru, Saudi Arabia, Spain, Thailand, and Vietnam. The company was formerly known as Prudential Pharmaceuticals Limited. Gennex Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
Corporate Governance
Gennex Laboratories Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 28, 2025 at 10:59 AM UTC - June 2, 2025 at 12:00 PM UTC
Gennex Laboratories Limited Earnings Date
Recent Events
September 10, 2001 at 12:00 AM UTC
Ex-Dividend Date